🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This double-blind 8 week study will evaluate dose response, efficacy (blood...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-06
Trial ID
NCT01150357
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of a fixed ...
Status
Completed
Location
Sites in USA
Start Date
2008-07
Trial ID
NCT00739596
Treatments Being Tested
The primary objective of this study is to determine which treatment will be...
Status
Unknown
Location
Department of Cardiology, Nagoya University Graduate School of Medicine
Start Date
2013-04
Trial ID
NCT01893788
Treatments Being Tested
To evaluate the efficacy and safety of aliskiren alone and in combination w...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-06
Trial ID
NCT00219180
Treatments Being Tested
This proof of concept study is designed to evaluate the efficacy and safety...
Status
Terminated
Location
Addenbrookes Hospital
Start Date
2008-03
Trial ID
NCT00542269
Treatments Being Tested
The purpose of the study was to evaluate the efficacy (blood pressure lower...
Status
Completed
Location
Investigative Site
Start Date
2010-10
Trial ID
NCT01237223
This study evaluated the effect of early initiation of aliskiren therapy, c...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-05
Trial ID
NCT00894387
The purpose of the study is to evaluate the blood pressure lowering effect ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2008-11
Trial ID
NCT00797316
Treatments Being Tested
The purpose of this study is to evaluate the effect of aliskiren, a novel d...
Status
Unknown
Location
Kurume University, School of Medicine
Start Date
2010-06
Trial ID
NCT01184599
Treatments Being Tested
The study will evaluate the efficacy and safety of both aliskiren monothera...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-03
Trial ID
NCT00853658